Weave Bio

Weave Bio is building the first AI-enabled regulatory platform for drug development. The existing processes to submit regulatory submissions to government bodies is extremely time consuming and expensive. Weave Bio is building a SaaS platform powered by LLMs to dramatically reduce the time spent producing regulatory documents (97% reduction in current benchmarks). The Weave Platform is the only AI-powered, regulatory automation management platform for the entire lifecycle of a therapeutic candidate. Weave's cloud-based software streamlines regulatory workflows, ensuring content is accurate, structured, consistent, and aligned with FDA and global standards. Built around the eCTD (electronic Common Technical Document) structure—the FDA’s standardized format for regulatory submissions—Weave intelligently leverages AI templates, organizes data, automatically drafts, and offers tool to rapidly develop, iterate on and validate submission-ready content.